Advertisement

Topics

Trovagene's application for AML drug accepted for FDA review

06:21 EDT 28 Jul 2017 | SmartBrief

The FDA has accepted for review Trovagene's investigational new drug application for PCM-075, its PLK1 inhibitor, as a treatm -More

Original Article: Trovagene's application for AML drug accepted for FDA review

NEXT ARTICLE

More From BioPortfolio on "Trovagene's application for AML drug accepted for FDA review"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...